Pharmacokinetics of single-dose ceftaroline fosamil in children with cystic fibrosis
Pediatric Pulmonology Sep 25, 2017
Le J, et al. - This paper explored the pharmacokinetics of single-dose ceftaroline fosamil in children with cystic fibrosis (CF). As the children with CF reported increased ceftaroline Clearance (CL) compared with published data from non-CF children, greater dosages could be needed in the children with CF. This would yield adequate exposure in the treatment of MRSA pneumonia. Pharmacodynamic-based dosing speculated that dosing ought to be based on the patient's MRSA MIC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries